Juan-Carlos Hernández-Boluda

81PUBLICATIONS
290CO-AUTHORS
Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Cardiovascular medicine and haematology not elsewhere classifiedHaematologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Aug 04, 2026
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

|Jul 15, 2026
Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY-1 and MOMENTUM Trials.

|Jul 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|Dec 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

Alexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster

|Oct 28, 2025
Optical genome mapping in myelofibrosis: enhancing prognostic accuracy through high-resolution genomic profiling.

Álvaro Díaz-González, Elvira Mora, Marta Garrote

Pageof 14

Frequent Collaborators

22 joint publications

Donal P McLornan

20 joint publications

Marie Robin

18 joint publications

Nicola Polverelli

14 joint publications

Tomasz Czerw